I disagree, IMU is dependant on results, not necessarily market forces. If the results for Vaxinia are good, given its unique ability to target difficult to treat solid tumours, the interest from all the leading players is going to be immense. Oncology is currently the leading player of interest in the cancer space, and YF has the opportunity to capitalise on this current trend. The SP shall follow. There is continued support as there has been for months around the 13 cent range as investors in the US and here know they are on a good thing. Theres a few traders in and out but volume is weak as most investors are holding and waiting..
I disagree, IMU is dependant on results, not necessarily market...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |